−17.2
Grace Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
−15.9
FY24:
−12.3
FY25:
−14.9
FY26:
−8.87
Change from FY22 to FY26
millions USD
FY22:
−3.52
FY23:
13.2
FY24:
0.10
FY25:
0
FY26:
0
millions USD
FY22:
0
FY23:
0.30
FY24:
7.36
FY25:
14.0
FY26:
3.71
millions USD
FY22:
−20.6
FY23:
−2.46
FY24:
−4.87
FY25:
−0.87
FY26:
−5.16
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−15.9
FY24:
−12.4
FY25:
−14.9
FY26:
–
All amounts in millions USD